Eli Lilly's Zepbound gains FDA approval as the first drug to directly treat obstructive sleep apnea in adults with obesity, potentially impacting prevalent insurance coverage barriers.
In-depth exploration of public anger towards the American health care system throughout history, potential for change, and Hollywood's portrayal of health insurance-related events.
Physician compensation remains a central concern in health care, influenced by educational debt, specialty-specific variations, and evolving employer policies.
Discover how telehealth-delivered cognitive behavioral therapy significantly reduced nightmare frequency, distress, and improved mental health symptoms in children aged 6 to 17 years, yielding potential suicide prevention benefits.
Investigate how screen time's indirect impact on sleep quality mediates behavioral problems in preschool children through a comprehensive Chinese study.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Expanded preoperative evaluations can reduce postoperative delirium by 23% in older adults, but frailty doubles the risk—are your patients screened effectively?
A recent study published in JAMA Dermatology revealed the significant efficacy of nemolizumab in reducing pruritus and skin lesions in patients with moderate to severe prurigo nodularis.
A recent study reveals the impact of the COVID-19 pandemic on sleep patterns in individuals with a history of depression, highlighting significant shifts in sleep duration and factors influencing these changes.
Explore innovative approaches, including mindfulness, team efficiency, and psilocybin therapy, to address clinician burnout and mental health challenges.